Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 182Breast 73Gynecologic 67Head & Neck 42Gastrointestinal 36Genitourinary 29Other solid neoplasm 20CNS 13Tumor-Agnostic 7Lymphoid 7Endocrine 4Dermatologic 4Sarcoma 3Other 2Classical hematology 2Other neoplasm 1Other hematologic neoplasm 1

Conditions

Salivary Gland Malignant Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Biopsy 3fludarabine 2Taxes 2Paclitaxel 2Endoscopic Mucosal Resection 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2venetoclax 1trametinib 1toripalimab 1thymoglobulin 1taxane 1sintilimab 1potassium oxonate 1lutetium Lu 177 dotatate 1gimeracil 1fludarabine phosphate 1dabrafenib 1apatinib 1Whole-Body Irradiation 1Watchful Waiting 1Transurethral Resection of Prostate 1Tegafur 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carboplatin × Other neoplasm × Clear all
NCT05000892 2022-12-02

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡